# Dentsply Sirona Inc. (XRAY)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $2.02B  
**Price:** $10.13 (+0.90%)

> Dentsply Sirona Inc. develops, manufactures, and markets professional dental products and technologies worldwide. It specializes in dental equipment supported by cloud-enabled solutions, alongside dental consumables and healthcare products for urology and enterology. The company operates through four key segments: Connected Technology Solutions, which provides imaging equipment, motorized handpieces, treatment centers, intraoral scanners, 3D printers, and mills like CEREC for chairside restorations; Essential Dental Solutions, offering endodontic, restorative, and preventive consumables; Orthodontic and Implant Solutions, featuring digital implant systems and orthodontic products; and Wellspect Healthcare, delivering continence care solutions for urinary and bowel management. These offerings serve dental professionals, orthodontists, oral surgeons, and healthcare providers, enhancing diagnostics, treatments, and patient care in dentistry and related fields. Founded in 1899 and headquartered in Charlotte, North Carolina, Dentsply Sirona Inc. plays a vital role in advancing oral health technologies and specialized medical consumables.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $3.68B | $1.84B | -$422M | -$598M | — |
| 2024 | $3.79B | $1.96B | -$879M | -$910M | — |
| 2023 | $3.96B | $2.09B | -$85M | -$132M | — |
| 2022 | $3.92B | $2.13B | -$937M | -$950M | — |
| 2021 | $4.23B | $2.35B | $608M | $411M | — |
| 2020 | $3.34B | $1.66B | -$3M | -$73M | — |
| 2019 | $4.02B | $2.16B | $353M | $256M | — |
| 2018 | $3.99B | $2.07B | -$958M | -$1.01B | — |
| 2017 | $3.99B | $2.19B | -$1.56B | -$1.55B | — |
| 2016 | — | $2.00B | $455M | $430M | — |
| 2015 | — | $1.52B | $375M | $251M | — |
| 2014 | — | $1.60B | $446M | $323M | — |
| 2013 | — | $1.58B | $419M | $313M | — |
| 2012 | $2.93B | $1.56B | $382M | $314M | — |
| 2011 | $2.54B | $1.27B | $301M | $245M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $5.43B | $4.09B | $1.34B | $326M | $2.28B |
| 2024 | $5.75B | $3.81B | $1.94B | $272M | $1.75B |
| 2023 | $7.37B | $4.08B | $3.29B | $334M | $1.91B |
| 2022 | $7.64B | $3.83B | $3.81B | $365M | $1.87B |
| 2021 | $9.24B | $4.24B | $5.00B | $339M | $1.92B |
| 2020 | $9.35B | $4.42B | $4.93B | $438M | $2.28B |
| 2019 | $8.60B | $3.51B | $5.09B | $405M | $1.44B |
| 2018 | $8.69B | $3.55B | $5.12B | $310M | $1.58B |
| 2017 | $10.37B | $3.75B | $6.62B | $321M | $1.63B |
| 2016 | $11.56B | $3.43B | $8.11B | $384M | $1.53B |
| 2015 | $4.40B | $2.06B | $2.34B | $285M | $1.15B |
| 2014 | $4.65B | $2.32B | $2.32B | $152M | $1.26B |
| 2013 | $5.08B | $2.50B | $2.54B | $75M | $1.37B |
| 2012 | $4.97B | $2.72B | $2.21B | $80M | $1.47B |
| 2011 | $4.76B | $2.87B | $1.85B | $77M | $1.49B |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $235M | — | — |
| 2024 | $461M | — | — |
| 2023 | $377M | — | — |
| 2022 | $517M | $149M | $368M |
| 2021 | $657M | $142M | $515M |
| 2020 | $649M | $87M | $562M |
| 2019 | $639M | $123M | $516M |
| 2018 | $500M | $183M | $317M |
| 2017 | $602M | $144M | $458M |
| 2016 | $563M | — | — |
| 2015 | $497M | — | — |
| 2014 | $560M | — | — |
| 2013 | $418M | — | — |
| 2012 | $370M | — | — |
| 2011 | $393M | — | — |

Source: [CompaniesByCap](https://companiesbycap.com/company/XRAY)